Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexagliflozin Monotherapy in Type 2 Diabetes
NCT02715258Phase 3Completed
- Sponsor
- Theracos, Inc.
- Start
- Mar 2016
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of bexagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Theracos, Inc.. Started Mar 2016; status: completed.
02
Drugs
bexagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02715258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02715258.